The company started with cardiac rhythm disease management. Over the span of 40 years, Medtronic is now operating in five other major business areas, which include surgical devices, neuromodulation, cardiovascular, diabetes, and spinal and biologics. The expanding portfolio of Medtronic is the result of the company’s continuing partnerships with physicians.
Medtronic’s innovations are born from 50 R&D centers around the world. The company’s partnership with doctors, often called open and close partnership, is the heart of all the innovative approaches. With the many cutbacks on healthcare budgets, Medtronic’s steady flow of revenues contributes to the increasing flow of new developments. Medtronic sees the expanding market and intensifying competition as opportunities for the creation of more effective medical devices.